centerforbiosimilars15 天
Aflibercept Biosimilar MYL-1701P Provides Equivalence in DME Therapy
The study findings demonstrate that the aflibercept biosimilar MYL-1701P is as effective and safe as the reference aflibercept in treating diabetic macular edema (DME), offering a promising option for ...
第一财经6 天
马应龙：MYL软膏获得药物临床试验批准通知书
马应龙晚间公告，收到国家药监局核准签发的关于MYL软膏（虎麝止血止痛膏）的《药物临床试验批准通知书》，将于近期开展临床试验。该药品功能 ...
pharmaphorum1 天
Mylan launches Advair generic at 70% discount in US
Mylan has launched its generic version of GlaxoSmithKline’s respiratory blockbuster, Advair, at a 70% discount compared with the original drug. Cheaper competition to off-patent Advair has been ...
搜狐6 天
痔疮不再让你烦恼！MYL软膏即将临床试验，你准备好了吗？
但你可知道，随着医学的发展，越来越多的新药正在攻克这一烦恼。最近，马应龙公司的MYL软膏获得了药物临床试验的批准，这让无数患有痔疮的人充满期待。究竟这个新药能带来怎样的改变呢？ 痔疮的成因多样，包括饮食不当、长时间久坐、便秘等，许多人在 ...
腾讯网6 天
马应龙：MYL软膏获得药物临床试验批准通知书
每经AI快讯，马应龙(600993)12月6日晚间公告，收到国家药监局核准签发的关于MYL软膏（虎麝止血止痛膏）的《药物临床试验批准通知书》，将于近期 ...
pharmaphorum2 天
Update: FDA clears first generic of AZ's blockbuster Symbicort
Viatris (formerly Mylan) has become the first drugmaker to win full FDA approval for a generic version of AstraZeneca's top-selling respiratory drug Symbicort, although launch plans remain ...